Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Alkermes Plc
(NQ:
ALKS
)
28.45
+0.10 (+0.35%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Alkermes Plc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Lots Of Deal News
June 29, 2021
Today Didi, a Chinese ride-hailing stock is doing its IPO reportedly at above the level projected in its application.
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Saint Warren
June 28, 2021
Today the WTI oil price rose further up over 1%.
Via
Talk Markets
Alkermes Announces Former Professional Baseball Player, CC Sabathia, as Spokesperson for Alcohol Dependence Awareness Campaign
June 24, 2021
SOURCE: Alkermes
Via
3BL Media
Exposures
COVID-19
Forget Biogen: These 2 Under-the-Radar Biotechs Are Also Celebrating Breakthroughs
June 13, 2021
Biogen isn't the only company whose shares should benefit from a breakthrough drug.
Via
The Motley Fool
Alkermes Celebrates Alcoholics Anonymous Founders Day
June 10, 2021
SOURCE: Alkermes
Via
3BL Media
The Boston Club Recognizes Alkermes plc and Blue Cross Blue Shield of Massachusetts With First President's Award
May 17, 2021
SOURCE: Alkermes
Via
3BL Media
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
June 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts
June 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,...
Via
Benzinga
The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal
June 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Aethlon Medical, Inc. (...
Via
Benzinga
Wednesday News And Catch-Up
June 09, 2021
Today the US market resumed its attempt to hit a new record for the S&P 500 and Nasdaq, but not the DJIA.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US
June 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 8) Agios Pharmaceuticals, Inc...
Via
Benzinga
Exposures
COVID-19
Product Safety
Juvenile Investing Mob
June 08, 2021
Tech stocks did well in Europe but not in the US. The data are unconvincing.
Via
Talk Markets
The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex
June 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 7) Agios Pharmaceuticals, Inc...
Via
Benzinga
Alkermes: Diversity Strengthens Our Culture
June 07, 2021
SOURCE: Alkermes
Via
3BL Media
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
June 07, 2021
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,...
Via
Benzinga
Exposures
Product Safety
A Better Switch
June 04, 2021
Today the US market decided to rise because President Biden is pondering not linking his infrastructure project to a corporate tax increase.
Via
Talk Markets
"I'm Incredibly Proud to Work at a Company Whose Mission Is To Help Families Like Mine"
June 02, 2021
SOURCE: Alkermes
Via
3BL Media
Alkermes Shares Move Higher On FDA Approval Of Schizophrenia, Bipolar Med
June 01, 2021
The FDA has approved Alkermes plc's (NASDAQ: ALKS) Lybalvi, a once-daily, oral atypical antipsychotic composed of olanzapine, an established antipsychotic...
Via
Benzinga
Exposures
Product Safety
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
Exposures
Product Safety
Alkermes Inspiration Grants® 2021 Applications Are Now Open
May 24, 2021
SOURCE: Alkermes
Via
3BL Media
Alkermes Celebrates Mental Health Month
May 19, 2021
SOURCE: Alkermes
Via
3BL Media
Exposures
COVID-19
Alkermes Announces 2021 Alkermes Inspiration Grants® Program to Support Innovative Programs Focused on People Affected by Addiction, Serious Mental Illness or Cancer
May 13, 2021
SOURCE: Alkermes
Via
3BL Media
Why Shares of Alkermes Rose 18% Last Month
May 07, 2021
An agreement with an activist investor capped a busy month.
Via
The Motley Fool
Want to Make Money in Biotech? Do This First
May 07, 2021
Keeping track of upcoming events is important.
Via
The Motley Fool
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
Alkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness Month
May 04, 2021
SOURCE: Alkermes
Via
3BL Media
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Regulatory
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs
April 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:...
Via
Benzinga
Alkermes PLC (ALKS) Q1 2021 Earnings Call Transcript
April 29, 2021
ALKS earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Alkermes Launches New Disease State Website to Offer Education About Alcohol Dependence
April 29, 2021
SOURCE: Alkermes
Via
3BL Media
Alkermes: Q1 Earnings Insights
April 28, 2021
Shares of Alkermes (NASDAQ:ALKS) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share increased 1000.00% year over year to $0.11,...
Via
Benzinga
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
April 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.